1. Home
  2. PTIX vs OBLG Comparison

PTIX vs OBLG Comparison

Compare PTIX & OBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • OBLG
  • Stock Information
  • Founded
  • PTIX 1994
  • OBLG 2000
  • Country
  • PTIX United States
  • OBLG United States
  • Employees
  • PTIX N/A
  • OBLG N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • OBLG Computer Software: Programming Data Processing
  • Sector
  • PTIX Health Care
  • OBLG Technology
  • Exchange
  • PTIX Nasdaq
  • OBLG Nasdaq
  • Market Cap
  • PTIX 3.7M
  • OBLG 4.4M
  • IPO Year
  • PTIX 2016
  • OBLG N/A
  • Fundamental
  • Price
  • PTIX $0.44
  • OBLG $3.60
  • Analyst Decision
  • PTIX
  • OBLG
  • Analyst Count
  • PTIX 0
  • OBLG 0
  • Target Price
  • PTIX N/A
  • OBLG N/A
  • AVG Volume (30 Days)
  • PTIX 377.2K
  • OBLG 34.7K
  • Earning Date
  • PTIX 11-14-2024
  • OBLG 11-07-2024
  • Dividend Yield
  • PTIX N/A
  • OBLG N/A
  • EPS Growth
  • PTIX N/A
  • OBLG N/A
  • EPS
  • PTIX N/A
  • OBLG N/A
  • Revenue
  • PTIX N/A
  • OBLG $2,759,000.00
  • Revenue This Year
  • PTIX N/A
  • OBLG N/A
  • Revenue Next Year
  • PTIX N/A
  • OBLG N/A
  • P/E Ratio
  • PTIX N/A
  • OBLG N/A
  • Revenue Growth
  • PTIX N/A
  • OBLG N/A
  • 52 Week Low
  • PTIX $0.43
  • OBLG $2.81
  • 52 Week High
  • PTIX $1.87
  • OBLG $14.80
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 39.26
  • OBLG 47.86
  • Support Level
  • PTIX $0.43
  • OBLG $3.33
  • Resistance Level
  • PTIX $0.52
  • OBLG $4.04
  • Average True Range (ATR)
  • PTIX 0.05
  • OBLG 0.33
  • MACD
  • PTIX -0.01
  • OBLG -0.04
  • Stochastic Oscillator
  • PTIX 6.74
  • OBLG 29.35

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About OBLG Oblong Inc.

Oblong Inc is a provider of patented multi-stream collaboration products and managed services for video collaboration and network solutions. The company's flagship product Mezzanine is the technology platform that defines computing: simultaneous multi-user, multi-screen, multi-device, and multi-location for dynamic and immersive visual collaboration. Mezzanine transforms routine meetings and workflows into agile, engaging experiences by making data visible and accessible in a collaborative setting. Mezzanine enables multiple, concurrent pieces of content to be shared, manipulated, created, and captured across distance. It serves various industries including aerospace, consulting, executive search, broadcast media, technology, financial services, education, healthcare, real estate.

Share on Social Networks: